Shi-Feng Huang (Shifeng Huang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Klebsiella Pneumoniae

Urinary Tract Infection

Top Venues

Infection and drug resistance

Microbiology spectrum

Antimicrobial resistance and infection control

This page only lists publications with an associated author ORCID identifier.

Publications

Qianrong Tu, Xiaoying Cao, Chao Ling, Lili Xiang, Ping Yang, Shi-Feng Huang
Point-of-care detection of Neisseria gonorrhoeae based on RPA-CRISPR/Cas12a. AMB Express 13 (1) (2023)
Xiaoying Cao, Yanbin Chang, Chunqing Tao, Sen Chen, Qiuxia Lin, Chao Ling, Shi-Feng Huang, Hengshu Zhang
Cas12a/Guide RNA-Based Platforms for Rapidly and Accurately Identifying Staphylococcus aureus and Methicillin-Resistant S. aureus. Microbiology spectrum (2023)
Wenjuan Feng, Si-Qiang Niu, Yanbin Chang, Xiaojiong Jia, Shi-Feng Huang, Ping Yang
Design of Rapid Detection System for Five Major Carbapenemase Families (bla KPC, bla NDM, bla VIM, bla IMP and bla OXA-48-Like) by Colorimetric Loop-Mediated Isothermal Amplification. Infection and drug resistance 14 (2021)
Yanhui Ding, Huijuan Wang, Shuli Pu, Shi-Feng Huang, Si-Qiang Niu
Resistance Trends of Klebsiella pneumoniae Causing Urinary Tract Infections in Chongqing, 2011-2019. Infection and drug resistance 14 (2021)
Qiuxia Lin, Hua Zou, Xian Chen, Menglu Wu, Deyu Ma, Hanbing Yu, Siqiang Niu, Shi-Feng Huang
Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro. BMC microbiology 21 (1) (2021)
De-Yu Ma, Han-Yu Huang, Hua Zou, Meng-Lu Wu, Qiu-Xia Lin, Bo Liu, Shi-Feng Huang
Carbapenem-Resistant Klebsiella aerogenes Clinical Isolates from a Teaching Hospital in Southwestern China: Detailed Molecular Epidemiology, Resistance Determinants, Risk Factors and Clinical Outcomes. Infection and drug resistance 13 (2020)
Li Yan, Jide Sun, Xiuyu Xu, Shi-Feng Huang
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrobial resistance and infection control 9 (1) (2020)
Hua Zou, Sen-Jie Xiong, Qiu-Xia Lin, Meng-Lu Wu, Si-Qiang Niu, Shi-Feng Huang
CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime-Avibactam And Aztreonam-Avibactam. Infection and drug resistance 12 (2019)